-- 据周三提交给澳大利亚证券交易所的文件显示，Emerald Resources（ASX：EMR）已获得西澳大利亚州水务和环境监管部门对其全资拥有的丁戈岭金矿项目的批准，该项目正式进入开发阶段。 文件显示，此次监管部门的批准涵盖了关键基础设施，包括选矿厂、发电站、尾矿库以及未来黄金生产所需的配套工程。 文件还指出，该公司已完成并启用了供施工和运营人员使用的现场住宿设施，并将持续钻探至2026年，以支持资源更新，包括露天矿的扩建和潜在的地下开发，同时推进首个矿石储量的估算。 此外，文件补充道，该公司已承诺投资约3000万澳元，用于为其丁戈岭金矿项目购置两台8000千瓦的美卓半自磨机以及一套破碎回路。
Related Articles
Asia
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
$HKG:2096
Asia
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
$HKG:1357
Asia
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.
$HKG:2158